Latest updates on chronic viral hepatitis B

Authors : Ramazan IDILMAN, Fatih KARAKAYA

Pages : 33-37

Doi:10.5472/MMJsi.2901.07

View : 14 | Download : 4

Publication Date : 2016-08-01

Article Type : Review Paper

Abstract :Hepatitis B virus insert ignore into journalissuearticles values(HBV); remains a major cause of liver-relatedmorbidity and mortality in Turkey and all over the world. Twodifferent types of antiviral agents can be used in the treatmentof chronic hepatitis B insert ignore into journalissuearticles values(CHB);. Conventional insert ignore into journalissuearticles values(IFN); or pegylatedinterferon alpha insert ignore into journalissuearticles values(PegIFN);, nucleoside [lamivudine insert ignore into journalissuearticles values(LMV);,telbivudine, emtricitabine, entecavir insert ignore into journalissuearticles values(ETV);] and nucleotide analogs[adefovir dipivoxil insert ignore into journalissuearticles values(ADV);] and tenofovir disoproxil fumarateinsert ignore into journalissuearticles values(TDF);]. Antiviral agent must ensure a degree of HBV viralsuppression and will lead to biochemical, serological remissionand histological improvement. Current treatment strategies arediscussed in present brief report.Keywords: Chronic hepatitis B, Nucleosinsert ignore into journalissuearticles values(t);ide analog, Entecavir,Tenofovir disoproxil fumarate
Keywords : Kronik hepatit B, Nükleoz t, id analog, Entekavir, Tenofovir disoproksil fumarat